Workup for Elevated Alkaline Phosphatase in a 12-Year-Old Girl
This 12-year-old girl requires immediate evaluation for bone and mineral metabolism disorders, particularly X-linked hypophosphatemia (XLH) or other phosphate-wasting disorders, alongside thyroid optimization and investigation of her systemic symptoms that suggest a possible autoimmune or infiltrative process.
Immediate Priority Laboratory Tests
The elevated alkaline phosphatase (259 U/L) with normal ALT (11 U/L) in a 12-year-old with joint pain, fatigue, and weight loss points away from primary liver disease and toward bone pathology or systemic disease. You must obtain the following tests immediately 1:
Essential First-Line Tests:
- Serum phosphorus (fasting, morning specimen)
- Serum calcium (corrected for albumin or ionized)
- Parathyroid hormone (PTH)
- 25-hydroxyvitamin D
- Morning spot urine phosphorus/creatinine ratio (collected simultaneously with serum)
- Kidney function (creatinine, eGFR)
- Complete blood count with differential
- Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)
Rationale for This Approach:
The combination of elevated ALP with diffuse joint pain and fatigue in a prepubertal/early pubertal girl raises concern for phosphate-wasting disorders like XLH, which characteristically presents with bone pain, muscle weakness/fatigue, and elevated ALP 1. While XLH typically manifests earlier, it can present with these features at age 12, particularly if mild.
Critical diagnostic pattern for XLH 1:
- Low serum phosphorus for age
- Normal calcium
- Normal or mildly elevated PTH (distinguishes from nutritional rickets)
- High ALP
- Normal or inappropriately low 1,25-dihydroxyvitamin D
Thyroid Management
Her TSH of 5.4 mIU/L represents mild subclinical hypothyroidism. While the 2004 JAMA guidelines suggest repeating TSH with free T4 in 2 weeks to 3 months 2, given her symptomatic presentation (severe fatigue, weight loss, urticaria), you should:
- Repeat TSH with free T4 now (within 2 weeks)
- Check anti-TPO antibodies to identify autoimmune thyroiditis
- If TSH remains >5.0 mIU/L with symptoms, strongly consider levothyroxine therapy even if TSH <10 mIU/L, as she is symptomatic and has concurrent systemic illness
Important caveat: The association between chronic urticaria and autoimmune thyroiditis is well-established 3. If anti-TPO antibodies are positive, thyroid optimization may help her urticaria, though evidence for L-thyroxine improving urticaria symptoms is mixed and shows no clear superiority over placebo 3.
Imaging Studies Required
Based on the clinical presentation, obtain:
- Bilateral knee and wrist radiographs to evaluate for rickets, rachitic changes, or bone lesions 1
- Renal ultrasound to screen for nephrocalcinosis (if phosphate disorder suspected)
- Consider bone survey if malignancy suspected based on initial workup
Differential Diagnosis Priority List
Most Likely Based on Age and Presentation:
Phosphate-wasting disorder (XLH or similar): Elevated ALP, bone/joint pain, fatigue, muscle weakness 1
Primary hyperparathyroidism: Can present with bone pain, elevated ALP, and genu valgum in children 4. Check PTH and calcium urgently.
Infiltrative bone disease: Malignancy with bone metastases is the most common cause of isolated elevated ALP in adults (57% of cases) 5, though less common in children. Weight loss is concerning.
Autoimmune/inflammatory conditions:
- Systemic lupus erythematosus or juvenile idiopathic arthritis (diffuse joint pain, urticaria, fatigue)
- Langerhans cell histiocytosis (can present with elevated ALP, systemic symptoms) 6
Subclinical hypothyroidism contributing to symptoms 2
Less likely but consider: Primary sclerosing cholangitis (rare in children, but can present with markedly elevated ALP) 7, 8
Critical Red Flags Requiring Urgent Action
- Weight loss of 7 lbs is concerning in a 12-year-old and warrants aggressive workup for malignancy or systemic disease
- Recurrent urticaria may indicate autoimmune process or mast cell disorder
- Diffuse joint pain at this age is not normal and requires explanation
Genetic Testing Consideration
If initial workup reveals hypophosphatemia with elevated/inappropriately normal FGF23, genetic testing for PHEX gene variants should be pursued to confirm XLH 1. Gene panel testing can include FGF23, DMP1, ENPP1, FAM20C, and other phosphate-wasting disorder genes 1.
Common Pitfalls to Avoid
- Do not assume elevated ALP is "normal for growth" in a symptomatic child with systemic complaints
- Do not delay workup waiting for TSH to normalize—the constellation of symptoms demands immediate investigation
- Do not miss malignancy: While rare in children, the weight loss and elevated ALP mandate thorough evaluation 5
- Do not forget age-adjusted reference ranges for phosphorus and ALP—these vary significantly in childhood 1
- Do not treat urticaria with L-thyroxine alone expecting resolution—evidence is conflicting and antihistamines remain first-line 3
Follow-Up Timeline
- Repeat labs and clinical assessment within 2 weeks
- If phosphate disorder confirmed, refer to pediatric endocrinology immediately for consideration of burosumab or conventional therapy 1
- If malignancy suspected, expedite imaging and oncology referral
- If autoimmune process identified, refer to pediatric rheumatology